Nita Radhakrishnan/OncoDaily
Aug 3, 2026, 08:57
Nita Radhakrishnan: Moving Beyond Half-Life in Hemophilia Prophylaxis at NHU 2026
Nita Radhakrishnan, Additional Professor and HOD of Pediatric Hematology-Oncology at Post Graduate Institute of Child Health, shared on LinkedIn:
“Discussed at NHU 2026 Indian Association for Haemophilia and Allied Disorders
Looking beyond t½ of EHL products: Individualized prophylaxis based on clearance, time above target, clinical phenotype, and shared decision-making.”

Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments